Clinical trial No longer in our active list Interventional Ages 55 to 70

Surgery for treating large idiopathic macular holes

Official title: Clinical Study of Translocated Internal Limiting Membrane Flap Reposition for the Treatment of Idiopathic Macular Hole

Run by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · NCT06063005 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing a new surgical method for treating large macular holes to see if it helps people see better and improves their quality of life compared to the standard surgery.

Quick facts

Study typeInterventional
Ages55 Years to 70 Years
SexAll
Enrollment76 (estimated)
SponsorXinhua Hospital, Shanghai Jiao Tong University School of Medicine
Academic / other
Locations1 site (Shanghai)
Trial IDNCT06063005 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals diagnosed with idiopathic macular holes measuring between 500 and 900 µm in diameter and who meet specific ocular criteria.

Probably not a fit

Patients with other retinal disorders or high myopia may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical study evaluates the effectiveness of a new surgical technique involving the translocation of the internal limiting membrane (ILM) flap compared to traditional surgery for large idiopathic macular holes. It is a prospective randomized controlled trial designed to assess improvements in visual function, anatomical healing of the retina, and overall quality of life for patients. Participants will undergo either the new surgical approach or the conventional method, with outcomes monitored through follow-up assessments.

Why it matters

Potential benefit: If successful, this approach could significantly improve visual outcomes and quality of life for patients with large idiopathic macular holes.

How similar studies have gone: While this approach is innovative, similar studies have shown promise in improving surgical outcomes for macular holes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants who can understand the purpose of this clinical trial, volunteer to participate, sign an informed consent form, and can complete the postoperative follow-up on time.
* Participants diagnosed with idiopathic macular hole (IMH).
* Based on OCT scans, the minimum horizontal diameter of the macular hole is \>500 and \<900 µm.
* Participants with an axial length \<26.0mm and a myopic degree lower than 6D.
* For participants with bilateral macular holes, the eye with a larger hole diameter will be included.

Exclusion Criteria:

* Patients with the following retinal disorders: age-related macular degeneration, epi-macular membrane neovascularization, non-macular retinal tears, lesions of the retinal pigment epithelium and choroid, inherited or degenerative retinal diseases, optic neuropathies, retinal vascular diseases; patients with large macular holes accompanied by retinal detachment;
* Patients with high myopia (axial length ≥ 26.0mm and myopia exceeding 6D);
* Patients with a history of ocular trauma or retinal laser treatment;
* Patients with glaucoma, ocular infections, inflammations, tumors, corneal diseases, or amblyopia;
* Patients with contraindications to vitrectomy;
* Patients with severe or unstable systemic diseases;
* Patients with a fasting blood glucose level ≥ 9mmol/L before surgery;
* Patients who participated in other clinical trials involving drugs or medical devices within 30 days prior to screening;
* Patients with a history of intraocular surgery within 3 months prior to screening;
* Patients with reduced visual function or vision in the contralateral eye as determined by the investigator;
* Patients who are not considered suitable for enrollment by the investigator for other reasons.

Where it's running

  • Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
    Shanghai, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.